Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery - Quiz - MDSpire

Incidence of Cataract Surgery in Patients Treated with Mirvetuximab Soravtansine: An Evaluation of Ocular Safety

By
Jordyn F. Silverstein
Alexandra Smick
Edmund Tsui
Oladunni Alomaja
Bridget Johnson
Chi-Hong Tseng
Ritu Salani
Dennis J. Slamon
Dana M. Chase
Gottfried E. Konecny
May 21, 2026

Jama Network Open

Share

Original Source(s)

Jama Network Open

Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery

by Jordyn F. Silverstein, Alexandra Smick, Edmund Tsui, Oladunni Alomaja, Bridget Johnson, Chi-Hong Tseng, Ritu Salani, Dennis J. Slamon, Dana M. Chase, Gottfried E. Konecny
May 21, 2026

Related Content

United States Department Of Health And Human Services

HHS and EPA Announce New Scientific Partnership to Strengthen Glyphosate Review

by Assistant Secretary for Public Affairs (ASPA)
September 22, 2026

Journal Of Neuro-Oncology

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis

Drug Safety

The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy

by Manfred Hauben, Rave Harpaz, Robert Weber
September 17, 2026